The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Deletion of Sarm1 gene is neuroprotective in two models of peripheral neuropathy
Open accessAbstract
Distal axon degeneration seen in many peripheral neuropathies is likely to share common molecular mechanisms with Wallerian degeneration. Although several studies in mouse models of peripheral neuropathy showed prevention of axon degeneration in the slow Wallerian degeneration (Wlds) mouse, the role of a recently identified player in Wallerian degeneration, Sarm1, has not been explored extensively. In this study, we show that mice lacking the Sarm1 gene are resistant to distal axonal degeneration in a model of chemotherapy induced peripheral neuropathy caused by paclitaxel and a model of high fat diet induced putative metabolic neuropathy. This study extends the role of Sarm1 to axon degeneration seen in peripheral neuropathies and identifies it as a likely target for therapeutic development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Increased Nuclear NAD Biosynthesis and SIRT1 Activation Prevent Axonal Degeneration
Araki, T., Sasaki, Y., & Milbrandt, J. (2004) · Science · doi:10.1126/science.1098014 · Cited by 1,060 · cited 1×
“The genetic mechanism by which axon degeneration is prevented in the Wlds mouse is ectopic expression of NMNAT1 protein in the axon (Araki et al., 2004).”
BackgroundAbsence of Wallerian Degeneration does not Hinder Regeneration in Peripheral Nerve
Lunn, E. R., Perry, V. H., Brown, M. C., Rosen, H., & Gordon, S. (1989) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1989.tb00771.x · Cited by 646 · cited 1×
“First was the identification of a spontaneous mutation that arose in a colony of mice resulted in delayed Wallerian degeneration when peripheral axons were crushed or cut (Lunn et al., 1989; Perry et al., 1990).”
BackgroundSARM1 activation triggers axon degeneration locally via NAD + destruction
Gerdts, J., Brace, E. J., Sasaki, Y., DiAntonio, A., & Milbrandt, J. (2015) · Science · doi:10.1126/science.1258366 · Cited by 593
Endogenous Nmnat2 Is an Essential Survival Factor for Maintenance of Healthy Axons
Gilley, J., & Coleman, M. P. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000300 · Cited by 472 · cited 1×
“Furthermore, overexpression of NMNAT2 (the axonal form of NMNAT) is sufficient to prevent axon degeneration, and reduction in levels of NMNAT2 in axons is sufficient to induce axon degeneration (Gilley and Coleman, 2010; Gilley et al., 2013).”
BackgroundA local mechanism mediates NAD-dependent protection of axon degeneration
Wang, J., Zhai, Q., Chen, Y., Lin, E., Gu, W., McBurney, M. W., & He, Z. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200504028 · Cited by 352
Dyslipidemia-Induced Neuropathy in Mice
Vincent, A. M., Hayes, J. M., McLean, L. L., Vivekanandan-Giri, A., Pennathur, S., & Feldman, E. L. (2009) · Diabetes · doi:10.2337/db09-0047 · Cited by 264
A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degeneration
Di Stefano, M., Nascimento-Ferreira, I., Orsomando, G., Mori, V, Gilley, J., Brown, R., Janeckova, L., Vargas, M. E., Worrell, L. A., Loreto, A., et al. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2014.164 · Cited by 246 · cited 1×
“…what had been described in the literature with traumatic axon degeneration (Osterloh et al., 2012) and models of vincristine-induced neurotoxicity (Geisler et al., 2016; Gerdts et al., 2013), these results suggest an important role for Sarm1 in axon degeneration induced by both toxic and…”
BackgroundLjungberg, M. C., Ali, Y. O., Zhu, J., Wu, C.-S., Oka, K., Zhai, R. G., & Lu, H.-C. (2012) · Human Molecular Genetics · doi:10.1093/hmg/ddr492 · Cited by 107 · cited 1×
“Another study using a mouse model of human tauopathy found that transcription of NMNAT2 was down-regulated prior to neurodegeneration and that overexpression of NMNAT2 or NMNAT1 was sufficient to reduce neurodegeneration (Ljungberg et al., 2012).”
Background
Cited by
Macrophage biology in the peripheral nervous system after injury
Zigmond, R. E., & Echevarria, F. D. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.12.001 · Cited by 368
SARM1 is a metabolic sensor activated by an increased NMN/NAD+ ratio to trigger axon degeneration
Figley, M. D., Gu, W., Nanson, J. D., Shi, Y., Sasaki, Y., Cunnea, K., Malde, A. K., Jia, X., Luo, Z., Saikot, F. K., et al. (2021) · Neuron · doi:10.1016/j.neuron.2021.02.009 · Cited by 324
Programmed axon degeneration: from mouse to mechanism to medicine
Coleman, M. P., & Höke, A. (2020) · Nature Reviews Neuroscience · doi:10.1038/s41583-020-0269-3 · Cited by 321
Self-citationFracture repair requires TrkA signaling by skeletal sensory nerves
Li, Z., Meyers, C. A., Chang, L., Lee, S., Li, Z., Tomlinson, R., Hoke, A., Clemens, T. L., & James, A. W. (2019) · Journal of Clinical Investigation · doi:10.1172/jci128428 · Cited by 269
New perspectives in diabetic neuropathy
Eid, S. A., Rumora, A. E., Beirowski, B., Bennett, D. L., Hur, J., Savelieff, M. G., & Feldman, E. L. (2023) · Neuron · doi:10.1016/j.neuron.2023.05.003 · Cited by 257
Axonal Degeneration during Aging and Its Functional Role in Neurodegenerative Disorders
Salvadores, N., Sanhueza, M., Manque, P., & Court, F. A. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00451 · Cited by 182
Metabolic stress drives sympathetic neuropathy within the liver
Liu, K., Yang, L., Wang, G., Liu, J., Zhao, X., Wang, Y., Li, J., & Yang, J. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.01.012 · Cited by 146
Gene therapy targeting SARM1 blocks pathological axon degeneration in mice
Geisler, S., Huang, S. X., Strickland, A., Doan, R. A., Summers, D. W., Mao, X., Park, J., DiAntonio, A., & Milbrandt, J. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20181040 · Cited by 145
Murata, H., Khine, C. C., Nishikawa, A., Yamamoto, K.-I., Kinoshita, R., & Sakaguchi, M. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004578 · Cited by 80
Implications of NAD metabolism in pathophysiology and therapeutics for neurodegenerative diseases
Hikosaka, K., Yaku, K., Okabe, K., & Nakagawa, T. (2021) · Nutritional Neuroscience · doi:10.1080/1028415x.2019.1637504 · Cited by 62
Axon Biology in ALS: Mechanisms of Axon Degeneration and Prospects for Therapy
Coleman, M. P. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01297-6 · Cited by 33
“Thus, loss of the main axonal NMNAT isoform, NMNAT2, a protein absolutely required for axon survival [63, 64] appears to be what provides the axonal specificity of degeneration after axon injury, or in axonal transport disorders [65, 66], or when NMNAT2 is genetically disrupted [64, 67, 68, 69], since NMNAT1 supplies…”
Background
Metadata
- Authors
- Turkiew, E., Falconer, D., Reed, N., & Höke, A.
- Venue
- Journal of the Peripheral Nervous System
- Publisher
- Wiley
- Published
- 2017-09
- Volume
- 22
- Issue
- 3
- Pages
- 162-171
- ISSN
- 1085-9489 (ISSN-L)
- 1529-8027
- OpenAlex
- W2613942025
- Cited by
- 179
- References
- 8
- FWCI
- 5.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.